SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,312,000 | +17.6% | 221,300 | -4.4% | 0.00% | 0.0% |
| Q1 2016 | $2,816,000 | -3.8% | 231,598 | +25.8% | 0.00% | 0.0% |
| Q4 2015 | $2,927,000 | +188.7% | 184,137 | +177.9% | 0.00% | +100.0% |
| Q3 2015 | $1,014,000 | -63.2% | 66,267 | -41.6% | 0.00% | -50.0% |
| Q2 2015 | $2,756,000 | +125.3% | 113,445 | +115.4% | 0.00% | +100.0% |
| Q1 2015 | $1,223,000 | -44.0% | 52,657 | -39.5% | 0.00% | 0.0% |
| Q4 2014 | $2,185,000 | -8.6% | 87,084 | +13.2% | 0.00% | 0.0% |
| Q3 2014 | $2,390,000 | +41.1% | 76,924 | +17.4% | 0.00% | 0.0% |
| Q2 2014 | $1,694,000 | +232.8% | 65,536 | +199.9% | 0.00% | – |
| Q1 2014 | $509,000 | +68.5% | 21,855 | +82.9% | 0.00% | – |
| Q4 2013 | $302,000 | -43.8% | 11,952 | -54.7% | 0.00% | – |
| Q3 2013 | $537,000 | – | 26,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |